Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1994 Aug 11;22(15):3202–3209. doi: 10.1093/nar/22.15.3202

Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides.

C F Bennett 1, M Y Chiang 1, L Wilson-Lingardo 1, J R Wyatt 1
PMCID: PMC310297  PMID: 8065936

Abstract

Phosphorothioate oligonucleotides were identified which directly inhibited human type II phospholipase A2 (PLA2) enzyme activity in a sequence specific manner. The minimum pharmacophore common to all oligonucleotides which inhibited PLA2 enzyme activity consisted of two sets of three or more consecutive guanosine residues in a row. These oligonucleotides appear to form G quartets resulting in the formation of oligonucleotide aggregates. Additionally, a phosphorothioate backbone was required to be effective inhibitors of type II PLA2. The activity of one oligodeoxynucleotide, IP 3196 (5'-GGGTGGGTATAGAAGGGCTCC-3') has been characterized in more detail. IP 3196 inhibited PLA2 enzyme activity when the substrate was presented in the form of a phospholipid bilayer but not when presented in the form of a mixed micelle with anionic detergents. Human type II PLA2 was 50-fold more sensitive to inhibition by IP 3196 than venom and pancreatic type I enzymes. These data demonstrate that phosphorothioate oligonucleotides can specifically inhibit human type II PLA2 enzyme activity in a sequence specific manner.

Full text

PDF
3202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbour S. E., Dennis E. A. Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells. J Biol Chem. 1993 Oct 15;268(29):21875–21882. [PubMed] [Google Scholar]
  2. Bennett C. F., McCarte A., Crooke S. T. Purification and characterization of a soluble phospholipase A2 from guinea pig lung. Biochim Biophys Acta. 1990 Dec 4;1047(3):271–283. doi: 10.1016/0005-2760(90)90526-4. [DOI] [PubMed] [Google Scholar]
  3. Bennett C. F., Mong S., Clarke M. A., Kruse L. I., Crooke S. T. Differential effects of manoalide on secreted and intracellular phospholipases. Biochem Pharmacol. 1987 Mar 1;36(5):733–740. doi: 10.1016/0006-2952(87)90727-1. [DOI] [PubMed] [Google Scholar]
  4. Bennett C. F., Spector D. L., Yeoman L. C. Nonhistone protein BA is a glutathione S-transferase localized to interchromatinic regions of the cell nucleus. J Cell Biol. 1986 Feb;102(2):600–609. doi: 10.1083/jcb.102.2.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blackburn E. H. The molecular structure of centromeres and telomeres. Annu Rev Biochem. 1984;53:163–194. doi: 10.1146/annurev.bi.53.070184.001115. [DOI] [PubMed] [Google Scholar]
  6. Bock L. C., Griffin L. C., Latham J. A., Vermaas E. H., Toole J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 1992 Feb 6;355(6360):564–566. doi: 10.1038/355564a0. [DOI] [PubMed] [Google Scholar]
  7. Chiang M. Y., Chan H., Zounes M. A., Freier S. M., Lima W. F., Bennett C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem. 1991 Sep 25;266(27):18162–18171. [PubMed] [Google Scholar]
  8. Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., Milona N., Knopf J. L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991 Jun 14;65(6):1043–1051. doi: 10.1016/0092-8674(91)90556-e. [DOI] [PubMed] [Google Scholar]
  9. Crooke S. T. Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol. 1992;32:329–376. doi: 10.1146/annurev.pa.32.040192.001553. [DOI] [PubMed] [Google Scholar]
  10. Crowl R. M., Stoller T. J., Conroy R. R., Stoner C. R. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991 Feb 5;266(4):2647–2651. [PubMed] [Google Scholar]
  11. Davidson F. F., Dennis E. A. Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J Mol Evol. 1990 Sep;31(3):228–238. doi: 10.1007/BF02109500. [DOI] [PubMed] [Google Scholar]
  12. Davidson F. F., Dennis E. A., Powell M., Glenney J. R., Jr Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem. 1987 Feb 5;262(4):1698–1705. [PubMed] [Google Scholar]
  13. Davidson F. F., Lister M. D., Dennis E. A. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line. J Biol Chem. 1990 Apr 5;265(10):5602–5609. [PubMed] [Google Scholar]
  14. Dennis E. A. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994 May 6;269(18):13057–13060. [PubMed] [Google Scholar]
  15. Fonteh A. N., Chilton F. H. Mobilization of different arachidonate pools and their roles in the generation of leukotrienes and free arachidonic acid during immunologic activation of mast cells. J Immunol. 1993 Jan 15;150(2):563–570. [PubMed] [Google Scholar]
  16. Gao W. Y., Storm C., Egan W., Cheng Y. C. Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol Pharmacol. 1993 Jan;43(1):45–50. [PubMed] [Google Scholar]
  17. Gattaz W. F., Hübner C. V., Nevalainen T. J., Thuren T., Kinnunen P. K. Increased serum phospholipase A2 activity in schizophrenia: a replication study. Biol Psychiatry. 1990 Sep 15;28(6):495–501. [PubMed] [Google Scholar]
  18. Hazen S. L., Hall C. R., Ford D. A., Gross R. W. Isolation of a human myocardial cytosolic phospholipase A2 isoform. Fast atom bombardment mass spectroscopic and reverse-phase high pressure liquid chromatography identification of choline and ethanolamine glycerophospholipid substrates. J Clin Invest. 1993 Jun;91(6):2513–2522. doi: 10.1172/JCI116487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Irvine R. F. How is the level of free arachidonic acid controlled in mammalian cells? Biochem J. 1982 Apr 15;204(1):3–16. doi: 10.1042/bj2040003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kang C., Zhang X., Ratliff R., Moyzis R., Rich A. Crystal structure of four-stranded Oxytricha telomeric DNA. Nature. 1992 Mar 12;356(6365):126–131. doi: 10.1038/356126a0. [DOI] [PubMed] [Google Scholar]
  21. Kaptain S., Downey W. E., Tang C., Philpott C., Haile D., Orloff D. G., Harford J. B., Rouault T. A., Klausner R. D. A regulated RNA binding protein also possesses aconitase activity. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10109–10113. doi: 10.1073/pnas.88.22.10109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kawasaki A. M., Casper M. D., Freier S. M., Lesnik E. A., Zounes M. C., Cummins L. L., Gonzalez C., Cook P. D. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem. 1993 Apr 2;36(7):831–841. doi: 10.1021/jm00059a007. [DOI] [PubMed] [Google Scholar]
  23. Kramer R. M., Hession C., Johansen B., Hayes G., McGray P., Chow E. P., Tizard R., Pepinsky R. B. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem. 1989 Apr 5;264(10):5768–5775. [PubMed] [Google Scholar]
  24. Kudo I., Murakami M., Hara S., Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta. 1993 Nov 3;1170(3):217–231. doi: 10.1016/0005-2760(93)90003-r. [DOI] [PubMed] [Google Scholar]
  25. Langlais J., Chafouleas J. G., Ingraham R., Vigneault N., Roberts K. D. The phospholipase A2 of human spermatozoa; purification and partial sequence. Biochem Biophys Res Commun. 1992 Jan 15;182(1):208–214. doi: 10.1016/s0006-291x(05)80132-9. [DOI] [PubMed] [Google Scholar]
  26. Leslie C. C. Kinetic properties of a high molecular mass arachidonoyl-hydrolyzing phospholipase A2 that exhibits lysophospholipase activity. J Biol Chem. 1991 Jun 15;266(17):11366–11371. [PubMed] [Google Scholar]
  27. Lin L. L., Lin A. Y., Knopf J. L. Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6147–6151. doi: 10.1073/pnas.89.13.6147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lister M. D., Deems R. A., Watanabe Y., Ulevitch R. J., Dennis E. A. Kinetic analysis of the Ca2+-dependent, membrane-bound, macrophage phospholipase A2 and the effects of arachidonic acid. J Biol Chem. 1988 Jun 5;263(16):7506–7513. [PubMed] [Google Scholar]
  29. Liu Z., Frantz J. D., Gilbert W., Tye B. K. Identification and characterization of a nuclease activity specific for G4 tetrastranded DNA. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3157–3161. doi: 10.1073/pnas.90.8.3157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mayer R. J., Marshall L. A. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J. 1993 Feb 1;7(2):339–348. doi: 10.1096/fasebj.7.2.8440410. [DOI] [PubMed] [Google Scholar]
  31. Minami T., Tojo H., Shinomura Y., Komatsubara T., Matsuzawa Y., Okamoto M. Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis. Am J Gastroenterol. 1993 Jul;88(7):1076–1080. [PubMed] [Google Scholar]
  32. Mulherkar R., Rao R., Rao L., Patki V., Chauhan V. S., Deo M. G. Enhancing factor protein from mouse small intestines belongs to the phospholipase A2 family. FEBS Lett. 1993 Feb 15;317(3):263–266. doi: 10.1016/0014-5793(93)81289-c. [DOI] [PubMed] [Google Scholar]
  33. Murakami M., Kudo I., Inoue K. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. J Biol Chem. 1993 Jan 15;268(2):839–844. [PubMed] [Google Scholar]
  34. Murakami M., Kudo I., Umeda M., Matsuzawa A., Takeda M., Komada M., Fujimori Y., Takahashi K., Inoue K. Detection of three distinct phospholipases A2 in cultured mast cells. J Biochem. 1992 Feb;111(2):175–181. doi: 10.1093/oxfordjournals.jbchem.a123733. [DOI] [PubMed] [Google Scholar]
  35. Nakazato Y., Simonson M. S., Herman W. H., Konieczkowski M., Sedor J. R. Interleukin-1 alpha stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a non-pancreatic (type II) phospholipase A2. J Biol Chem. 1991 Jul 25;266(21):14119–14127. [PubMed] [Google Scholar]
  36. Noponen M., Sanfilipo M., Samanich K., Ryer H., Ko G., Angrist B., Wolkin A., Duncan E., Rotrosen J. Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry. 1993 Nov 1;34(9):641–649. doi: 10.1016/0006-3223(93)90157-9. [DOI] [PubMed] [Google Scholar]
  37. Parthasarathy S., Barnett J. Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9741–9745. doi: 10.1073/pnas.87.24.9741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pearson A. M., Rich A., Krieger M. Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J Biol Chem. 1993 Feb 15;268(5):3546–3554. [PubMed] [Google Scholar]
  39. Pernas P., Masliah J., Olivier J. L., Salvat C., Rybkine T., Bereziat G. Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release. Biochem Biophys Res Commun. 1991 Aug 15;178(3):1298–1305. doi: 10.1016/0006-291x(91)91035-b. [DOI] [PubMed] [Google Scholar]
  40. Pruzanski W., Keystone E. C., Sternby B., Bombardier C., Snow K. M., Vadas P. Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. J Rheumatol. 1988 Sep;15(9):1351–1355. [PubMed] [Google Scholar]
  41. Pruzanski W., Scott K., Smith G., Rajkovic I., Stefanski E., Vadas P. Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Inflammation. 1992 Oct;16(5):451–457. doi: 10.1007/BF00918971. [DOI] [PubMed] [Google Scholar]
  42. Pruzanski W., Vadas P. Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis. J Rheumatol. 1988 Nov;15(11):1601–1603. [PubMed] [Google Scholar]
  43. Reynolds L. J., Hughes L. L., Louis A. I., Kramer R. M., Dennis E. A. Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2. Biochim Biophys Acta. 1993 Apr 23;1167(3):272–280. doi: 10.1016/0005-2760(93)90229-3. [DOI] [PubMed] [Google Scholar]
  44. Scott D. L., White S. P., Browning J. L., Rosa J. J., Gelb M. H., Sigler P. B. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. Science. 1991 Nov 15;254(5034):1007–1010. doi: 10.1126/science.1948070. [DOI] [PubMed] [Google Scholar]
  45. Seilhamer J. J., Plant S., Pruzanski W., Schilling J., Stefanski E., Vadas P., Johnson L. K. Multiple forms of phospholipase A2 in arthritic synovial fluid. J Biochem. 1989 Jul;106(1):38–42. doi: 10.1093/oxfordjournals.jbchem.a122815. [DOI] [PubMed] [Google Scholar]
  46. Seilhamer J. J., Randall T. L., Johnson L. K., Heinzmann C., Klisak I., Sparkes R. S., Lusis A. J. Novel gene exon homologous to pancreatic phospholipase A2: sequence and chromosomal mapping of both human genes. J Cell Biochem. 1989 Mar;39(3):327–337. doi: 10.1002/jcb.240390312. [DOI] [PubMed] [Google Scholar]
  47. Sharp J. D., White D. L., Chiou X. G., Goodson T., Gamboa G. C., McClure D., Burgett S., Hoskins J., Skatrud P. L., Sportsman J. R. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem. 1991 Aug 15;266(23):14850–14853. [PubMed] [Google Scholar]
  48. Shoeman R. L., Wadle S., Scherbarth A., Traub P. The binding in vitro of the intermediate filament protein vimentin to synthetic oligonucleotides containing telomere sequences. J Biol Chem. 1988 Dec 15;263(35):18744–18749. [PubMed] [Google Scholar]
  49. Singh R., Green M. R. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science. 1993 Jan 15;259(5093):365–368. doi: 10.1126/science.8420004. [DOI] [PubMed] [Google Scholar]
  50. Smith F. W., Feigon J. Quadruplex structure of Oxytricha telomeric DNA oligonucleotides. Nature. 1992 Mar 12;356(6365):164–168. doi: 10.1038/356164a0. [DOI] [PubMed] [Google Scholar]
  51. Thunnissen M. M., Ab E., Kalk K. H., Drenth J., Dijkstra B. W., Kuipers O. P., Dijkman R., de Haas G. H., Verheij H. M. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor. Nature. 1990 Oct 18;347(6294):689–691. doi: 10.1038/347689a0. [DOI] [PubMed] [Google Scholar]
  52. Vadas P., Keystone J., Stefanski E., Scott K., Pruzanski W. Induction of circulating group II phospholipase A2 expression in adults with malaria. Infect Immun. 1992 Sep;60(9):3928–3931. doi: 10.1128/iai.60.9.3928-3931.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wang K. Y., McCurdy S., Shea R. G., Swaminathan S., Bolton P. H. A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA. Biochemistry. 1993 Mar 2;32(8):1899–1904. doi: 10.1021/bi00059a003. [DOI] [PubMed] [Google Scholar]
  54. Weisman-Shomer P., Fry M. QUAD, a protein from hepatocyte chromatin that binds selectively to guanine-rich quadruplex DNA. J Biol Chem. 1993 Feb 15;268(5):3306–3312. [PubMed] [Google Scholar]
  55. Wery J. P., Schevitz R. W., Clawson D. K., Bobbitt J. L., Dow E. R., Gamboa G., Goodson T., Jr, Hermann R. B., Kramer R. M., McClure D. B. Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution. Nature. 1991 Jul 4;352(6330):79–82. doi: 10.1038/352079a0. [DOI] [PubMed] [Google Scholar]
  56. Williams K. R., Reddigari S., Patel G. L. Identification of a nucleic acid helix-destabilizing protein from rat liver as lactate dehydrogenase-5. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5260–5264. doi: 10.1073/pnas.82.16.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wu-Pong S., Weiss T. L., Hunt C. A. Antisense c-myc oligodeoxyribonucleotide cellular uptake. Pharm Res. 1992 Aug;9(8):1010–1017. doi: 10.1023/a:1015846209681. [DOI] [PubMed] [Google Scholar]
  58. Wyatt J. R., Vickers T. A., Roberson J. L., Buckheit R. W., Jr, Klimkait T., DeBaets E., Davis P. W., Rayner B., Imbach J. L., Ecker D. J. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1356–1360. doi: 10.1073/pnas.91.4.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES